Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nimodipine in ischemic cerebropathy]

G Di Lascio1, S Salvini

  • 1Divisione di Medicina, Ospedale Civile Polispecializzato di Anzio.

La Clinica Terapeutica
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of central and peripheral keratometric parameters after corneal collagen cross-linking in keratoconus patients.

International ophthalmology·2018
Same author

Linking the Psychosocial Impact of Assistive Devices Scale (PIADS) to the International Classification of Functioning, Disability, and Health.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2018
Same author

Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort.

European journal of clinical nutrition·2009
Same author

Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition.

European journal of clinical nutrition·2009
Same author

[Cytomegalovirus-induced protein-losing gastropathy: a case report].

La Pediatria medica e chirurgica : Medical and surgical pediatrics·2007
Same author

The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study.

European journal of clinical nutrition·2007

Nimodipine effectively treated acute and chronic cerebrovascular disorders in fifty patients. This calcium channel blocker demonstrated therapeutic benefits and good tolerability, even aiding in blood pressure stabilization for hypertensive individuals.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Cerebrovascular disorders encompass a range of conditions affecting brain blood supply.
  • Effective management of both acute and chronic cerebral ischemia remains a clinical challenge.

Purpose of the Study:

  • To evaluate the therapeutic efficacy and tolerability of nimodipine in patients with acute and chronic cerebrovascular disorders.
  • To assess nimodipine's impact on blood pressure in hypertensive patients with cerebrovascular conditions.

Main Methods:

  • A cohort of fifty patients with acute and chronic cerebrovascular disorders received oral nimodipine (90 mg daily) for 1 to 3 months.
  • Treatment included various forms of cerebrovascular pathology such as transient ischemic attacks (TIA), reversible ischemic neurological deficits (RIND), minor strokes, complete strokes, and chronic cerebral ischemia.

Related Experiment Videos

  • Patient outcomes, drug tolerability, and effects on blood pressure were monitored.

    • Main Results:

    • Nimodipine demonstrated therapeutic utility in managing both acute cerebrovascular events and chronic cerebral ischemia.
    • The drug was well-tolerated systemically and locally across the patient cohort.
    • In patients with coexisting arterial hypertension, nimodipine contributed to reduced blood pressure, showing a trend towards stabilization at near-normal levels.

    Conclusions:

    • Oral nimodipine is an effective treatment option for a spectrum of acute and chronic cerebrovascular disorders.
    • Nimodipine offers a favorable safety profile and ease of administration.
    • The drug may provide additional benefits in managing hypertension associated with cerebrovascular disease.